Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Preferred Stock Liabilities: 2019

  • Burning Rock Biotech's Preferred Stock Liabilities was N/A to $216.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was $216.7 million, marking a year-over-year change of. This contributed to the annual value of $221.2 million for FY2019, which is N/A change from last year.
  • According to the latest figures from Q4 2019, Burning Rock Biotech's Preferred Stock Liabilities is $216.7 million.
  • In the past 5 years, Burning Rock Biotech's Preferred Stock Liabilities registered a high of $216.7 million during Q4 2019, and its lowest value of $216.7 million during Q4 2019.
  • Its 1-year average for Preferred Stock Liabilities is $216.7 million, with a median of $216.7 million in 2019.